GLI2 and neoplasm: Higher expression of GLI2 was correlated with lower primary tumor stage (T1-2 vs. T3-4, p = 0.036), no lymphatic invasion (absent vs. present, p = 0.034), and no tumor recurrence (absent vs. present, p = 0.011).